ITRM920869A0 - Medicamenti per trattare condizioni infiammatorie o per analgesia. - Google Patents

Medicamenti per trattare condizioni infiammatorie o per analgesia.

Info

Publication number
ITRM920869A0
ITRM920869A0 IT92RM869A ITRM920869A ITRM920869A0 IT RM920869 A0 ITRM920869 A0 IT RM920869A0 IT 92RM869 A IT92RM869 A IT 92RM869A IT RM920869 A ITRM920869 A IT RM920869A IT RM920869 A0 ITRM920869 A0 IT RM920869A0
Authority
IT
Italy
Prior art keywords
analgesia
medicines
inflammatory conditions
treat inflammatory
treat
Prior art date
Application number
IT92RM869A
Other languages
English (en)
Inventor
Roger Stables
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919126027A external-priority patent/GB9126027D0/en
Priority claimed from GB929206083A external-priority patent/GB9206083D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ITRM920869A0 publication Critical patent/ITRM920869A0/it
Publication of ITRM920869A1 publication Critical patent/ITRM920869A1/it
Application granted granted Critical
Publication of IT1256697B publication Critical patent/IT1256697B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ITRM920869A 1991-12-06 1992-12-04 Medicamenti per trattare condizioni infiammatorie o per analgesia. IT1256697B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919126027A GB9126027D0 (en) 1991-12-06 1991-12-06 Medicaments
GB929206083A GB9206083D0 (en) 1992-03-20 1992-03-20 Medicaments

Publications (3)

Publication Number Publication Date
ITRM920869A0 true ITRM920869A0 (it) 1992-12-04
ITRM920869A1 ITRM920869A1 (it) 1994-06-04
IT1256697B IT1256697B (it) 1995-12-12

Family

ID=26299971

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM920869A IT1256697B (it) 1991-12-06 1992-12-04 Medicamenti per trattare condizioni infiammatorie o per analgesia.

Country Status (26)

Country Link
US (1) US5466436A (it)
EP (1) EP0550083B1 (it)
JP (1) JPH05246853A (it)
KR (1) KR930009605A (it)
AP (1) AP324A (it)
AT (1) AT401468B (it)
AU (1) AU664574B2 (it)
BE (1) BE1007268A3 (it)
CA (1) CA2084568A1 (it)
CH (1) CH685537A5 (it)
CZ (1) CZ358092A3 (it)
DE (1) DE69228738D1 (it)
DK (1) DK0550083T3 (it)
ES (1) ES2130152T3 (it)
FR (1) FR2684554B1 (it)
GB (1) GB2262036B (it)
GR (1) GR3030426T3 (it)
IE (1) IE922866A1 (it)
IL (1) IL103978A (it)
IT (1) IT1256697B (it)
LU (1) LU88196A1 (it)
MX (1) MX9207008A (it)
MY (1) MY108146A (it)
NO (1) NO303670B1 (it)
NZ (1) NZ245365A (it)
PH (1) PH31380A (it)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501560D0 (en) 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
JPH10512877A (ja) * 1995-01-26 1998-12-08 ニコムド イメージング エイ／エス ビスマス化合物
TR199901101T2 (xx) * 1996-11-22 1999-07-21 The Procter & Gamble Company Gastroenstentinal hastal�klar�n tedavisine y�nelik bizmut ve nsaid i�eren bile�imler.
EP0941101A1 (en) * 1996-11-22 1999-09-15 The Procter & Gamble Company Compositions for the treatment of gastrointestinal disorders containing bismuth, and nsaid and one or more antimicrobials
SE0000773D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
SE0000774D0 (sv) 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
JP2004520422A (ja) * 2001-03-08 2004-07-08 アストラゼネカ・アクチエボラーグ 新しい用途
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
EP1411900B2 (en) 2001-06-01 2013-12-04 Pozen, Inc. PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs
SE0102993D0 (sv) 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
US8067451B2 (en) * 2006-07-18 2011-11-29 Horizon Pharma Usa, Inc. Methods and medicaments for administration of ibuprofen
CA2615496C (en) * 2005-07-18 2014-11-18 Horizon Therapeutics, Inc. Medicaments containing famotidine and ibuprofen and administration of same
US20080021078A1 (en) * 2006-07-18 2008-01-24 Horizon Therapeutics, Inc. Methods and medicaments for administration of ibuprofen
US20080020040A1 (en) * 2006-07-18 2008-01-24 Horizon Therapeutics, Inc. Unit dose form for administration of ibuprofen
US8067033B2 (en) * 2007-11-30 2011-11-29 Horizon Pharma Usa, Inc. Stable compositions of famotidine and ibuprofen
WO2008027963A2 (en) * 2006-08-31 2008-03-06 Horizon Therapeutics, Inc. Nsaid dose unit formulations with h2-receptor antagonists and methods of use
EA201100313A1 (ru) 2008-09-09 2011-10-31 Астразенека Аб Способ доставки фармацевтической композиции пациенту, нуждающемуся в этом
CA2764963C (en) 2009-06-25 2016-11-01 Astrazeneca Ab Method for treating a patient at risk for developing an nsaid-associated ulcer
BR112014016085A8 (pt) 2011-12-28 2017-07-04 Pozen Inc composições aprimoradas e métodos para distribuição de omeprazol mais ácido acetilsalicílico
CN110893233A (zh) * 2019-12-19 2020-03-20 川北医学院附属医院 一种鸢尾素在制备抗炎药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464679A (en) * 1981-07-06 1984-08-07 Rca Corporation Method and apparatus for operating a microprocessor in synchronism with a video signal
CY1398A (en) * 1981-09-04 1987-12-18 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
CA1211374A (en) * 1982-05-14 1986-09-16 Eszter Cholnoky Pharmaceutical compositions containing more active ingredients
US4757060A (en) * 1986-03-04 1988-07-12 Bristol-Myers Company Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 and H2, receptor blockers
GB8625325D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Chemical compounds
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
EP0282132B1 (en) * 1987-03-09 1992-09-30 The Procter & Gamble Company Compositions and their use for treating gastrointestinal disorders
CH679582A5 (it) * 1988-07-18 1992-03-13 Glaxo Group Ltd
NZ235877A (en) * 1989-11-02 1992-09-25 Mcneil Ppc Inc Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions

Also Published As

Publication number Publication date
CZ358092A3 (en) 1993-10-13
GR3030426T3 (en) 1999-09-30
GB9225174D0 (en) 1993-01-20
NO924704L (no) 1993-06-07
ATA240692A (de) 1996-02-15
NO303670B1 (no) 1998-08-17
DE69228738D1 (de) 1999-04-29
KR930009605A (ko) 1993-06-21
AT401468B (de) 1996-09-25
CA2084568A1 (en) 1993-06-07
IE922866A1 (en) 1993-06-16
LU88196A1 (fr) 1993-08-17
US5466436A (en) 1995-11-14
NZ245365A (en) 1997-06-24
FR2684554B1 (fr) 1995-09-08
EP0550083A1 (en) 1993-07-07
MX9207008A (es) 1993-06-01
BE1007268A3 (fr) 1995-05-09
MY108146A (en) 1996-08-30
JPH05246853A (ja) 1993-09-24
IL103978A0 (en) 1993-05-13
AU2986392A (en) 1993-06-10
CH685537A5 (fr) 1995-08-15
AU664574B2 (en) 1995-11-23
FR2684554A1 (fr) 1993-06-11
GB2262036B (en) 1996-01-03
AP9200453A0 (en) 1993-01-31
NO924704D0 (no) 1992-12-04
GB2262036A (en) 1993-06-09
DK0550083T3 (da) 1999-10-11
ES2130152T3 (es) 1999-07-01
ITRM920869A1 (it) 1994-06-04
AP324A (en) 1994-03-07
PH31380A (en) 1998-10-29
EP0550083B1 (en) 1999-03-24
IT1256697B (it) 1995-12-12
IL103978A (en) 1998-06-15

Similar Documents

Publication Publication Date Title
ITRM920869A1 (it) Medicamenti per trattare condizioni infiammatorie o per analgesia.
FI934949A7 (fi) Paonytt tillslutbar laoda foer granulat
DK0553907T3 (da) Gevinddannende skrue.
FI914657A0 (fi) Digitalt audiointerface i gsm -anordning.
FI921311A0 (fi) Matrisdisplay med stereoskopiskt system.
FI921435A0 (fi) Skydd foer saenkpump i svaora foer- haollanden.
FI922759A0 (fi) Loesningsmedelskompositioner foer anvaendning i tryckkaensligt kopieringspapper.
FI912922L (fi) Anordning foer tilltraede i flexibla behaollare.
FI940896A7 (fi) Suojakaideliittimet
MX9203919A (es) Procedimiento para purificar organopolisiloxanos.
FI922180A0 (fi) Tuggummi innehaollande tuggummibas i en valsningsblandning.
FI915126L (fi) Mineraloljemellandestillat med foerbaettrade flytegenskaper i koeld.
FI920094A0 (fi) Bettjusteringsanordning foer betthuvud i traeflishuggare.
FI915127L (fi) Mineraloljemellandestillat med foerbaettrade flytegenskaper i koeld.
IT1244638B (it) Dispositivo per eliminare formazione di peluria.
DE59204156D1 (de) Schraube.
BR9202187A (pt) Alca de tracao para ziper
FI922818A0 (fi) Av en kropp framstaelld planformig formdel.
DE69113026D1 (de) Kontinuierliche Dispergiervorrichtung.
FI921786A0 (fi) Farmaceutisk foerening.
FI921785A0 (fi) Farmaceutisk foerening.
FI920998A0 (fi) Skaermad hytt i modulkonstruktion.
NO914123D0 (no) Korrosjonsbeskyttet j-roer
FI920443A0 (fi) Polyolefinfilmer i flera skikt.
FI920701A0 (fi) Anordning foer terapeutisk tryck- behandling.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19961227